Pharma C Investments - Appointment of Director
22/02/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230222:nRSV5971Qa&default-theme=true
RNS Number : 5971Q Pharma C Investments PLC 22 February 2023
22 February 2023
Pharma C Investments PLC
("Pharma C" or the "Company")
Appointment of Director
Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder
in the medical cannabis industry with a particular focus on companies that
provide ancillary products and services to the medicinal cannabis sectors, is
pleased to announce the appointment of Mr. Jeremy Woodgate to the Board of
Directors, with immediate effect.
Gavin Sathianathan, Investment Strategy Director, commented:
"I am pleased to welcome Jeremy to the board of Pharma C and look forward to
working closely with him to deliver on our mission to invest in high-growth
companies."
Jeremy Woodgate
Mr. Woodgate graduated as an Engineer in 2008 and started his career as a
corporate stockbroker specializing in raising finance for resources companies
with gold companies a particular focus. Working at Pareto Securities (formerly
Ocean Equities), Mr. Woodgate was promoted to Head of Trading in 2010 and
became a Partner in 2012, working on large equity and bond transactions
primarily in the resources and shipping sectors. In 2015, Mr. Woodgate founded
Smaller Company Capital Ltd. which listed the first publicly traded Blockchain
business. Smaller Company Capital Ltd. went on to finance and list numerous
technology and resources companies. Mr. Woodgate now sits on the board of a
number of companies across the resource, tech and sports sectors.
Mr. Woodgate has an interest of 2,528,617 Common Shares in the Company.
Current Directorships Former Directorships and/or partnerships (within the last five years)
Shelby Logistics Limited Vue Carbon Limited
White Bear Resources Ltd Kryptonite Can Limited
Axies Ventures Ltd Kryptonite 1 Limited
Ludus Gaming Ltd Providence Capital Partners Limited
One Hundred Group Ltd
States Bridge Capital Limited
JJW Holdings Limited
Smaller Company Capital Limited
Except as set out above, there is no further information regarding Jeremy
Woodgate that is required to be disclosed pursuant to Rule 4.9 of the AQSE
Growth Market Access Rulebook.
- ENDS -
The Director of the Company accepts responsibility for the contents of this
announcement.
This announcement contains inside information for the purposes of Article 7 of
the EU Regulation 596/2014 as it forms part of the UK law by virtue the
European Union (Withdrawal) Act 2018
For further information please visit www.pharmacinvestments.com
(http://www.pharmacinvestments.com/)
For additional information please contact:
Pharma C Investments
Gavin Sathianathan, Investment Strategy Director
gavin@pharmacinvestments.com
Novum Securities (AQSE Corporate Adviser)
Tel: +44 207 399 9400
David Coffman
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NEXFFLFLXLLEBBX